Arrowhead Pharmaceuticals | 8-K: Current report
Mar 19 16:42 ET
Arrowhead Pharmaceuticals | 8-K/A: Current report (Amendment)
Mar 18 15:37 ET
Arrowhead Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Feb 28 22:29 ET
Arrowhead Pharmaceuticals | DEFA14A: Others
Feb 27 17:15 ET
Arrowhead Pharmaceuticals | 8-K: Current report
Feb 22 14:40 ET
Arrowhead Pharmaceuticals | 8-K: Arrowhead Pharmaceuticals Reports Fiscal 2024 First Quarter Results
Feb 6 16:08 ET
Arrowhead Pharmaceuticals | DEF 14A: Definitive information statements
Jan 26 17:32 ET
Arrowhead Pharmaceuticals | DEFA14A: Others
Jan 26 17:31 ET
Arrowhead Pharmaceuticals | 8-K: Current report
Jan 22 00:00 ET
Arrowhead Pharmaceuticals | 8-K: Current report
Jan 4 00:00 ET
Arrowhead Pharmaceuticals | 8-K: Current report
Dec 5, 2023 17:16 ET
Arrowhead Pharmaceuticals | 8-K: Current report
Nov 29, 2023 16:10 ET
Arrowhead Pharmaceuticals | 8-K: Arrowhead Pharmaceuticals Reports Fiscal 2023 Second Quarter Results
Aug 7, 2023 16:10 ET
Arrowhead Pharmaceuticals | 8-K: Arrowhead Pharmaceuticals Reports Fiscal 2023 Second Quarter Results
May 2, 2023 16:09 ET
Arrowhead Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mar 23, 2023 13:41 ET
Arrowhead Pharmaceuticals | 8-K: Current report
Mar 20, 2023 17:48 ET
Arrowhead Pharmaceuticals | 8-K: Current report
Feb 15, 2023 08:34 ET
Arrowhead Pharmaceuticals | 8-K: Current report
Feb 14, 2023 17:18 ET
Arrowhead Pharmaceuticals | 8-K: Current report
Feb 7, 2023 20:41 ET
Arrowhead Pharmaceuticals | 8-K: Arrowhead Pharmaceuticals Reports Fiscal 2023 First Quarter Results
Feb 6, 2023 16:02 ET
No Data
No Data